IL2 and metastatic melanoma: Another option for the chemotherapy in patients with metastatic melanoma is the use of termozolomide (TMZ) p.o. followed by subcutaneous (s.c.)low-dose interleukin-2 (IL2), granulocyte-monocyte colony stimulating factor (GM-CSF), and interferon-alpha 2b (IFN alpha).